Expression of multiple protein 4.1 isoforms in erythroid progenitors and in a variety of nonerythroid tissues results from alternative pre-mRNA splicing. In 4.1 pre-mRNA, several translation initiation sites are present; synthesis of isoforms larger than 80 kD occurs when an upstream 5' AUG is spliced in, whereas the 80-kD mature erythroid isoform is produced when the upstream AUG is spliced out and translation is initiated at the downstream AUG. During erythropoiesis, this splicing switch is developmentally regulated. We studied this developmental switch in hereditary elliptocytosis 4.1"'O. in which a DNA rearrangement involving the exon containing the downstream AUG results in loss of coding capacity for the 80-kD 4.1, leading to mature red blood cells LTERNATIVE PRE-MRNA splicing is a powerful and frequently used molecular mechanism for creating structurally and functionally diverse protein isoforms from a single gene. Developmental-as well as tissue-specific usage of alternative exons enables the generation of isoforms that differ from one another in their functional activities. The protein 4.1 gene was one of the early genes to be characterized as generating multiple gene products as a result of alternative RNA ~plicing."~ A complex pattern of alternative splicing of protein 4.1 pre-mRNA is responsible for expression of multiple 4.1 isoforms in erythroid progenitors during erythropoiesis and in a variety of nonerythroid tissues.'-'.'-'') The principal protein 4.1 isoform expressed in mature red blood cell (RBC) membranes is an 80-kD isoform that is plasma membrane-associated and plays a crucial role in regulating the mechanical strength of the membrane."." In erythroblasts and other nonerythroid cells, 4.1 isoforms also localize to cytoplasmic as well as nuclear regions, strongly suggesting a wide variety of roles for this isoform family in regulating cell f~n c t i o n . '~l~~" "~ H owever, only the plasma membrane-associated 80-kD isoform from the mature RBC has been functionally characterized. In the circulating erythrocyte, the 80-kD 4.1 engages in a number of protein-protein interactions crucial in regulating membrane strength and re- 
sistance to in vivo fragmentation.1X-2') As a component of the plasma membrane skeleton, it forms a ternary complex with spectrin and actin.20~2h In addition, it anchors the membrane skeleton to the lipid bilayer by interacting with the integral proteins band 3 and glycophorin C (in association with
Previous studies of 4.1 gene expression have indicated that early erythroid precursors can use both splice acceptor sites of the 5' 17-nt exon (Fig I) . thereby generating two populations of mature 4.1 mRNA: one that includes the upstream AUG (AUG-I) and encodes high molecular weight isoforms of 4.1 protein and another that skips AUG-I and encodes 80-kD 4.1 protein by initiation at the downstream AUG (AUG-2) in the 213-nt exon.',' During erythropoiesis. an alternative splicing switch at the splice acceptor site of the 17-nt exon leads to predominant skipping of AUG-I ; translation initiation switches to AUG-2 for synthesis of only 80-kD 4. l protein in more mature erythroid cells. ' To understand the implications of this developmentally regulated splicing switch, we studied developmental-specific use of protein 4.1 translation initiation sites during erythropoiesis in an Algerian family with hereditary elliptocytosis (HE) in which the homozygous phenotype is associated with markedly decreased membrane mechanical stability and a transfusion-dependent hemolytic anemia.'? Molecular analysis of the mutant HE 4.1 A'F gene showed a DNA rearrangement involving the 105-nt and 213-nt exons that encode AUG-2 and the N-terminus of 80-kD 4. showed that 4.I'''< mRNA retained AUG-I, but its coding region (-2.2 kb) was shorter than that of normal 4.1 mRNA (-2.5 kb). Southern blot analysis showed that the 105-nt exon was not present in the -2.2-kb mutant cDNA. When mutant erythroblasts were analyzed by immunofluorescence microscopy and by Western blot using antibodies generated against various 4.1 peptide sequences, we observed protein 4. I isoforms immunoreactive with the antipeptide antibodies.
These data unequivocally document the presence of 4.1 RNA and protein expression in HE 4.1"'g erythroblasts. Based on these observations, we conclude that. during erythropoiesis, developmental-specific use of protein 4. I translation initiation sites results in the presence of 4.1 in HE 4.l"le erythroblasts and the absence of 4.1 in HE 4. IAlg mature erythrocytes. These studies emphasize the importance of differentiationregulated RNA splicing because. within the same tissue, the mutant phenotype did not become apparent until after the differentiation-associated splicing event.
MATERIALS AND METHODS

Cells.
After obtaining informed consent from the subject, bone marrow was collected at the time of splenectomy from the affected by an overnight incubation at 3 7 T , 5% CO2 in o minimum essential medium (OMEM) supplemented with 10% fetal calf serum (FCS). Nonadherent cells were collected, counted, and resuspended in semisolid medium containing 0.8% methylcellulose, 30% FCS, 1% deionized bovine serum albumin (BSA; Stem Cell Technologies, Vancouver, British Columbia, Canada), recombinant human stem cell factor (SCF; 20 to 50 ng/mL), recombinant human interleukin-3 (IL-3; 5 to I O ng/mL), and recombinant human erythropoietin (Epo; 3 IU/ mL). Plates were incubated at 37"C, 5% CO2 and erythroid colonies derived from mature and primitive burst-forming unit-erythroid (BFU-E) were plucked sequentially during the next 5 to 12 days.
Day-5 erythroid colonies contained very immature erythroblasts, whereas erythroblasts in day-l2 colonies were hemoglobinized and at the polychromatophilic-acidophilic stage, as determined from observations of May-Grunwald-Giemsa-stained cytospun slides. Control erythroblasts were obtained following the same procedure from colony assays initiated with mononuclear cells isolated from either normal bone marrow aspirates or normal bone fragments collected during hip surgery.
After informed consent was obtained, fibroblasts were cultured from a skin biopsy specimen obtained from the affected member of the Algerian family. RNA isolation. Reticulocyte mRNA was isolated as previously described from the blood of patients with sickle cell anemia undergoing exchange transf~sion.'~ RNA from BFU-E-derived erythroblasts and fibroblasts was prepared using the method of Chirgwin et aLzs RT-PCR. RT-PCR was performed as previously described.' For amplification of the entire coding domain, an additional 15 minutes at 72°C was added to the final cycle. The amplification products were analyzed by 5% PAGE or 0.7% agarose gel electrophoresis.
Southern analysis. RT-PCR amplification products were separated on a 0.7% agarose gel in Tris-Acetate buffer. The gel was denatured and neutralized and the DNA was transferred in 20X SSC (3 mol/L sodium chloride, 0.3 molL sodium citrate solution) onto a nitrocellulose membrane. The membrane was prehybridized in 50% formamide, 3X SSC, 0.5% sodium dodecyl sulfate (SDS), 1
mol/L Tris, 2 x Denhardt's reagent (0.40 g/mL polyvinylpyrrolidone [PVP], 0.40 g/mL BSA, 0.04 g/ mL Ficoll), and 0.2 mg/mL salmon sperm DNA solution at 37°C overnight. The membrane was first analyzed with a 105-nt exon 5'-specific probe (GCGAATTCATGCTAAGGGACAAGATTTG) 3' end-labeled with [yZzP] ATP using T, polynucleotide kinase. A total of 2 X IO6 CPM was hybridized overnight at 50°C and then washed two times at 25°C with 2X SSC, 0.5% SDS; two times at 25°C with 2 x SSC, 0.1 % SDS; and one time at 50°C with 0.1 X SSC, 0. I % SDS before autoradiography. The blot was stripped by two 15-minute washes with a boiling solution of 0.05X SSC, 0.1% SDS, 0.01 moln EDTA. The membrane was prehybridized in the same manner as mentioned above and then reanalyzed using a probe that spanned from the downstream AUG to the C-terminus (Fig l) . This probe was labeled with [a3*P] dCTP using Amersham's random prime labeling system (Amersham, Arlington Heights, IL). A total of 1 x IO6 CPM was hybridized overnight at 37°C and washed as described above except more stringently by increasing to two 30-minute washes at 50°C with 0.1 X SSC, 0.5% SDS before autoradiography.
Antibodies. Polyclonal monospecific antibodies to a 34 amino acid peptide (24-2) from the alternatively expressed 102-nt exon in the 22 to 24-kD carboxy terminal regions were generated by immunizing rabbits with peptide coupled to bovine thyroglobulin. Antibodies were affinity-purified on Affi-Gel 10 (Bio-Rad Laboratories, Richmond, CA).
I~nrnunocytochrrnistty. Western blot analysis was performed ax previously described using the enhanced chemiluminescencc horwradish peroxidase detection reagents (Amersham)."
For immunofluorescence microscopy, cells were layered onto poly-l.-lysine-. coated slides, fixed, and permeabilized in acetone on dry ice. The cells were then incubated sequentially in primary antibody and in fluorescein isothiocyanate (F1TC)-conjugated goat antirabbit IgG (Cappel Laboratories, Cohranville, PA).
RESULTS
HE 4.IAIK erythroblasts express 4.1 RNA containing the upstream AUG-I. To compare alternative splicing events in mutant erythroblasts to those that occur in normal erythroblasts, RNA was prepared from mutant and normal BFU-E-derived erythroblasts at the late basophilic and polychromatophilic stage.
These RNA species were analyzed by RT-PCR using oligonucleotide primer set 1 (Table 1 ) , which spans the entire coding domain beginning within the upstream 5' translation initiation site. The major band in normal BFU-E-derived erythroblasts was -2.5 kb, whereas the major band in HE 4.IAlg BFT-E-derived erythroblasts was -2.2 kb (Fig IA) , consistent with our earlier report of a 3 18-nt deletion in 4.1 reticulocyte mRNA. The PCR products were then analyzed by Southern blot with a 105-nt exon 5"specific probe (Table I , primer set 11, sense primer). This probe was used because earlier work has shown that the 105-nt exon and the 213-nt exon (containing AUG-2) are deleted together."'.'' Southern blot analysis showed strong hybridization to the 2.5-kb band from the normal cells but no hybridization to the 2.2-kb band from the mutant cells (Fig IC) .
When the blot was reprobed (after stripping) with an -1 .Xkb-labeled cDNA that spanned from AUG-2 to the C-terminus, both the 2.5-kb band from the normal erythroblasts and the 2.2-kb band from the mutant erythroblasts hybridized (Fig lB) , thereby documenting that the 2.2-kb band was indeed protein 4.1 cDNA. From this series of experiments, we concluded that HE 4.1 erythroblasts do express protein 4.1 RNA species. Furthermore, the 105-nt exon was deleted in the mutant RNA, consistent with our previous observations of an aberrant splicing pattern resulting from rearrangement of the HE 4.lAIg gene in this region.
Mutunt erythroblasts and mutunt jibroblasts similtrrly splice the 213-nt and 105-nt exons.
To characterize the aberrant splicing pattern in more detail and to determine whether there was any influence on the pattern as a consequence of tissue-specific splicing, we compared RT-PCR amplification products derived from mutant erythroblasts and mutant fibroblasts. Using primer set 111 (Table I ) to amplify a portion of the N-terminal extension and the 213-and 105-nt exons, an 835-bp fragment was amplified from normal reticulocyte and normal fibroblast cDNAs (Fig 2) . In contrast, a 517-bp fragment amplified from both the mutant erythroblast and the mutant fibroblast derived cDNAs. The smaller band observed in the mutant cDNA was consistent with deletion of the 105-nt and 2 13-nt exons. To confirm this deletion, we tested directly for the presence of one of the two deleted exons, the 105-nt exon, using a set of primers spanning this exon ( fication products observed from either mutant erythroblast or mutant fibroblast cDNA (Fig 3) . These results strongly indicate that the 105-nt exon is completely excluded from 4.1"IF mRNA. Moreover, from these data, we conclude that, despite potential differences between erythroblast and fibroblast RNA splicing mechanisms, no tissue-specific differences in the aberrant splicing patterns of HE 4.IAlC precursor mRNA existed. (Fig 1) . The presence or absence of 4. I isoforms in mutant erythroblasts was initially evaluated by performing immunofluorescence microscopy with antibody 24-2. When mutant BFU-E-derived erythroblasts were probed with anti 24-2, specific fluorescence staining was observed, indicating that 4.1 isoform(s) containing peptide 24-2 was expressed in these cells (Fig 4) . The fluorescence pattern was punctate and, predominantly, cytoplasmic, which was very similar to what we 30kD ylycophorin binding extention 
t5
. . For reported earlier for normal BFU-E-derived erythroblasts probed with antibody 24-2: To characterize mutant erythroblast 4.1 isoforms in greater detail, the erythroid progenitors were analyzed by Western blot. As shown in Fig 5, when normal erythroblasts were probed with antibody 24-2, immunoreactive protein bands of -135 kD and -80 kD were present as well as a number of minor, smaller bands. Mutant erythroblasts probed with the same antibody contained a similar quantity of the -135-kD species, but the protein band appeared to migrate slightly faster, suggesting that the mutant isoform was smaller than the normal isoform. A decrease in size of the mutant isoform compared with the normal isoform would be consistent with the 318-nt deletion observed in the mutant RNA. HE 4.lAIe erythroblasts contained dramatically less immunoreactive protein in the 80-kD region compared with normal cells. The broad band observed in this region in the normal erythroblasts may represent several isoforms of close molecular weights, some of which were not expressed in the mutant cells.
DISCUSSION
Because the protein 4.1 gene contains at least 12 alternatively expressed exons and at least two translation initiation sites, it is not surprising that immunoreactive isoforms varying in size from 30 to 210 kD have been described in mammalian and avian erythroid and nonerythroid We have previously analyzed normal erythroblasts at various stages of differentiation and observed a number of isoforms ranging in size from 135 to 69 kD? From the current studies it is clear that the HE 4.lAIe erythroblasts also synthesize a variety of isoforms using the 5' upstream translation initiation site, AUG-l.
During normal erythropoiesis, usage of AUG-1 and AUG-2 is developmentally regulated, with AUG-I spliced in at early stages of development and spliced out in the more mature cell? Our current data indicate that the HE 4.lAIE mutation does not perturb the developmentally regulated use of AUG-I. Not yet elucidated is the functional activity of the 209 amino acid sequence encoded when translation is initiated at this upstream AUG. However, it is clear that this sequence is present in isoforms in erythroid and nonerythroid tissue and that its translatability is shut down later during erythropoiesis by splicing out AUG-l .4.9.10 Using antibodies to a synthetic peptide within this 209 amino acid stretch, we have observed by immunofluorescence microscopy that preproerythroblasts contain a circular perinuclear foci of fluorescence suggestive of a centro~ome.~ On the basis of these observations, it is tantalizing to speculate that 4.1 isoforms containing this 209 amino acid sequence may play a functional role in the mitotic process. Consistent with this thesis is the fact that the HE 4.1A'g phenotype appears to be limited to hemolytic anemia with no apparent abnormalities in erythropoiesis. Indeed, in the homozygous phenotype, erythroid development seems to proceed normally in the bone marrow, with erythroblasts undergoing orderly cell division indicative of a functioning mitotic apparatus. The final step in erythropoiesis, that of nuclear expulsion, also occurs normally in HE 4.lAIg, resulting in abundant reticulocytes. In addition, both clinical and experimental observations suggest that nonerythroid tissue function is apparently normal in affected individuals. Clinically, HE 4.IAlP signs and symptoms are limited to hemolytic anemia and earlier experimental studies in our laboratory showed that HE 4.lAle lymphocytes and fibroblasts both expressed protein 4.1 .lo These data, together with those of Huang et emphasize that AUG-1 is used for translation initiation of 4. l isoforms in nonerythroid tissues.
Interestingly, a second developmentally regulated splicing event in 4.1 mRNA also plays an important role in determining the phenotype of another form of HE. This splicing switch involves the 63-nt exon that encodes the amino acid sequence involved in interaction with spectrin and actin. The 21 amino acids encoded by the alternatively spliced 63-nt exon are mechanically crucial for mature RBC membrane strength. 20 We have previously shown that, during normal human erythropoiesis, there is a splicing switch involving this structurally crucial exon. Using nuclease protection assays, we observed that preproerythroblasts and erythroblasts cultured for 8 days expressed little of the 63-nt exon, whereas greater than 99% of reticulocyte RNA was +63. Using Western blot analysis, it was apparent that increasing amounts of the 4.1 isoform containing the 21 amino acid sequence were assembled on the membrane during very late erythroid differentiation.' Therefore, it appears that the protein-protein interactions produced by the presence on the plasma membrane of a 4.1 isoform expressing the 63-nt exon are functionally crucial in the more mature cell. Protein 4.Iw6' associated with HE is a truncated form of the 80-kD erythrocyte isoform with a deletion of 80 amino acids, resulting in removal of the entire spectrin-actin binding d~main.'~.'' In this phenotype we would predict that, as in HE 4.lAIg, erythroblasts would express 4.1 isoforms translated from AUG-1. However, in this form of HE, the developmentally regulated 63-nt exon splicing switch occumng late in differentiation accounts for the phenotype of marked membrane instability in circulating mature RBCS.'~ Based on our current data, we propose that erythroblast 4. lAlg mRNA splices in AUG-1 and can therefore synthesize 4.1 isoforms containing the amino terminal extension (Fig 6) . In contrast, the reticulocyte 4.lAIK mRNA lacks both AUG-1, as a result of developmental regulated splicing, and the downstream AUG-2, as a result of the mutation. With knockout of both translation initiation sites, 4.1 isoform synthesis is blocked, resulting in the HE phenotype of the mature RBC. These studies emphasize the crucial role of differentiationregulated RNA splicing because, within the same erythroid tissue, the mutant phenotype does not appear until after the differentiation-associated splicing event.
